HUP0203028A3 - Pharmaceutical formulation containing tolterodine and its use - Google Patents

Pharmaceutical formulation containing tolterodine and its use

Info

Publication number
HUP0203028A3
HUP0203028A3 HU0203028A HUP0203028A HUP0203028A3 HU P0203028 A3 HUP0203028 A3 HU P0203028A3 HU 0203028 A HU0203028 A HU 0203028A HU P0203028 A HUP0203028 A HU P0203028A HU P0203028 A3 HUP0203028 A3 HU P0203028A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical formulation
formulation containing
containing tolterodine
tolterodine
pharmaceutical
Prior art date
Application number
HU0203028A
Other languages
English (en)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56290073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0203028(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/SE1999/002052 external-priority patent/WO2000027364A1/en
Priority claimed from SE0000782A external-priority patent/SE0000782D0/xx
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of HUP0203028A2 publication Critical patent/HUP0203028A2/hu
Publication of HUP0203028A3 publication Critical patent/HUP0203028A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU0203028A 1999-11-11 2000-10-24 Pharmaceutical formulation containing tolterodine and its use HUP0203028A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/SE1999/002052 WO2000027364A1 (en) 1998-11-11 1999-11-11 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
SE0000782A SE0000782D0 (sv) 1999-11-11 2000-03-09 Pharmaceutical formulation and its use
PCT/SE2000/002061 WO2001034139A1 (en) 1999-11-11 2000-10-24 Pharmaceutical formulation containing tolterodine and its use

Publications (2)

Publication Number Publication Date
HUP0203028A2 HUP0203028A2 (hu) 2003-02-28
HUP0203028A3 true HUP0203028A3 (en) 2005-07-28

Family

ID=56290073

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203028A HUP0203028A3 (en) 1999-11-11 2000-10-24 Pharmaceutical formulation containing tolterodine and its use

Country Status (24)

Country Link
US (1) US6630162B1 (hu)
EP (1) EP1227806B1 (hu)
JP (1) JP2003513918A (hu)
KR (2) KR100838930B1 (hu)
CN (1) CN100353935C (hu)
AT (1) ATE300941T1 (hu)
AU (1) AU784104B2 (hu)
BR (1) BR0015346A (hu)
CA (1) CA2387973C (hu)
CZ (1) CZ304671B6 (hu)
DE (1) DE60021749T2 (hu)
DK (1) DK1227806T3 (hu)
EE (1) EE05191B1 (hu)
ES (1) ES2245320T3 (hu)
HK (1) HK1054196B (hu)
HU (1) HUP0203028A3 (hu)
MX (1) MXPA02004574A (hu)
NO (1) NO20022264D0 (hu)
NZ (1) NZ518309A (hu)
PL (1) PL356166A1 (hu)
PT (1) PT1227806E (hu)
SI (1) SI1227806T1 (hu)
SK (1) SK6412002A3 (hu)
WO (1) WO2001034139A1 (hu)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
CA2387973C (en) * 1999-11-11 2009-12-22 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use
WO2003053428A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Controlled release dosage form having improved drug release properties
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
EP1572173B1 (en) * 2002-12-13 2010-04-28 Warner-Lambert Company LLC Alpha-2-delta ligand to treat lower urinary tract symptoms
EP1589958B2 (en) * 2003-01-22 2012-04-11 Pfizer Health AB Reduced dose of tolterodine for treating urinary disorders
SE0300830D0 (sv) * 2003-03-26 2003-03-26 Pharmacia Ab New formulations and use thereof
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2004105735A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Controlled release pharmaceutical compositions of tolterodine and processes for their preparation
WO2005105036A1 (en) * 2004-04-28 2005-11-10 Natco Pharma Limited Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
EP1629834A1 (en) † 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
CN100382794C (zh) * 2004-08-30 2008-04-23 鲁南制药集团股份有限公司 酒石酸托特罗定的分散片剂型
CN1795845B (zh) * 2004-12-23 2010-10-13 李又欣 作为毒蕈碱受体拮抗剂的3，3-二苯基丙胺衍生物注射用缓释微球制剂
CN1330297C (zh) * 2005-07-04 2007-08-08 宛六一 酒石酸托特罗定软胶囊及其制备方法
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
CZ2006506A3 (cs) * 2006-08-09 2007-10-03 Zentiva, A. S. Farmaceutická kompozice s obsahem tolterodinu
KR100851033B1 (ko) * 2007-02-12 2008-08-12 명문제약주식회사 엘-주석산 톨터로딘 함유 서방성 제제의 제조방법
KR20080094473A (ko) * 2007-04-20 2008-10-23 한국화학연구원 음이온성 지질나노입자 및 이의 제조방법
WO2009003724A1 (en) * 2007-07-03 2009-01-08 Synthon B.V. Tolterodine bead
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8110226B2 (en) 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
WO2009019599A2 (en) 2007-08-08 2009-02-12 Themis Laboratories Private Limited Extended release compositions comprising tolterodine
EP2231124A1 (en) * 2007-12-20 2010-09-29 Pharmathen S.A. Sustained-release pharmaceutical formulation containing an antimuscarinic agent and a wetting agent as well as a process for the preparation thereof
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
WO2010096820A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled release compositions comprising anti-cholinergic drugs
US9078830B2 (en) 2009-07-31 2015-07-14 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
BR112012015084A2 (pt) 2009-12-23 2017-03-07 Lupin Ltd composição farmacêutica de liberação lenta de iloperidone
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
CA2796877A1 (en) 2010-04-30 2011-11-03 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US8392016B2 (en) 2010-06-25 2013-03-05 LNT PM Inc. Adaptive method for manufacturing of complicated shape parts by hot isostatic pressing of powder materials with using irreversibly deformable capsules and inserts
RU2671575C2 (ru) 2011-05-10 2018-11-02 Теравида, Инк. Применение солифенацина и стимуляторов слюноотделения в лечении гиперактивного мочевого пузыря
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
KR102266091B1 (ko) 2013-10-07 2021-06-17 임팩스 라보라토리즈, 인코포레이티드 레보도파 및/또는 레보도파의 에스테르의 점막-점착성, 제어 방출형 제제 그리고 이의 용도
EP3182970A4 (en) * 2014-08-22 2018-03-21 Medipath Inc. Compositions and methods for cannabinoid coatings for use in drug delivery
CN108697688A (zh) 2016-01-20 2018-10-23 塞拉维达公司 用于治疗多汗症的方法和组合物
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
US5382600A (en) 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
JP3786684B2 (ja) 1992-05-13 2006-06-14 アルザ・コーポレーション オキシブチニンの経皮投与
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
JPH0710745A (ja) * 1993-06-22 1995-01-13 Tanabe Seiyaku Co Ltd 放出開始時間制御型腸デリバリー経口製剤
JP3453186B2 (ja) * 1994-04-14 2003-10-06 共和薬品工業株式会社 徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
WO1996012477A1 (en) 1994-10-21 1996-05-02 Leiras Oy Controlled release oral delivery system containing oxybutynin
US5567441A (en) 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
AU728395B2 (en) * 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU4421697A (en) 1996-09-19 1998-04-14 American Home Products Corporation Method of treating urinary incontinence
JPH11193271A (ja) * 1997-10-31 1999-07-21 Ss Pharmaceut Co Ltd アリール酢酸アミド誘導体又はその塩及びこれを含有する医薬
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
SE9803871D0 (sv) * 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US6770295B1 (en) * 1998-08-27 2004-08-03 Pharmacia Ab Therapeutic formulation for administering tolterodine with controlled release
CA2387973C (en) * 1999-11-11 2009-12-22 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use

Also Published As

Publication number Publication date
PL356166A1 (en) 2004-06-14
US6630162B1 (en) 2003-10-07
HK1054196B (zh) 2008-08-01
MXPA02004574A (es) 2004-09-10
CZ304671B6 (cs) 2014-08-27
SK6412002A3 (en) 2002-09-10
NZ518309A (en) 2003-05-30
KR20070091374A (ko) 2007-09-10
BR0015346A (pt) 2002-06-25
EE05191B1 (et) 2009-08-17
CZ20021617A3 (cs) 2002-11-13
HK1054196A1 (en) 2003-11-21
JP2003513918A (ja) 2003-04-15
SI1227806T1 (sl) 2005-12-31
CN100353935C (zh) 2007-12-12
DK1227806T3 (da) 2005-10-31
KR100838930B1 (ko) 2008-06-16
PT1227806E (pt) 2005-10-31
ES2245320T3 (es) 2006-01-01
DE60021749D1 (de) 2005-09-08
HUP0203028A2 (hu) 2003-02-28
AU1319201A (en) 2001-06-06
CN1420767A (zh) 2003-05-28
EP1227806B1 (en) 2005-08-03
ATE300941T1 (de) 2005-08-15
EP1227806A1 (en) 2002-08-07
NO20022264L (no) 2002-05-13
AU784104B2 (en) 2006-02-02
DE60021749T2 (de) 2006-04-20
CA2387973C (en) 2009-12-22
EE200200245A (et) 2003-06-16
CA2387973A1 (en) 2001-05-17
KR20020062302A (ko) 2002-07-25
NO20022264D0 (no) 2002-05-13
WO2001034139A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
HUP0203028A3 (en) Pharmaceutical formulation containing tolterodine and its use
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0203895A3 (en) Substituted azaindoles and pharmaceutical compositions containing them and their use
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0202338A2 (en) Pharmaceutical composition containing fenofibrate and preparation method
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
GB0101035D0 (en) Formulation and use thereof
IL145715A0 (en) Formulation arrays and use thereof
HUP0104034A3 (en) Dosage form comprising liquid formulation
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
GB9818927D0 (en) Pharmaceutical formulation
IL144525A0 (en) Benzamide derivatives and drugs containing the same
GB9909154D0 (en) Pharmaceutical formulation
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use
EP1154783A4 (en) RELAXIN-CONTAINING MEDICAMENTS AND ITS USE
HUP0200336A3 (en) Pharmaceutical effervescent formulation containing metamizol
IL149101A0 (en) Pharmaceutical formulation containing tolterodine and its use
GB9926251D0 (en) Pharmaceutical formulation
ZA200202767B (en) Pharmaceutical formulation containing tolterodine and its use.
GB9802617D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal